Daftar pustaka antraks

1. Bisnis Indonesia.2000. Sepuluh Propinsi Berbahaya Untuk Lokasi Peternakan. 07 Mei 2000.

2. Brooks GF et al.1996. Mikrobiologi Kedokteran.Ed 20.hal 194-196.

3. Chin J.2006.Manual Pemberantasan Penyakit Menular.Ed 17. hal 23-30.

4. Dharmojono. 2000. Anthrax, Penyakit Ternak Mengejutkan Tetapi Tidak Mengherankan. Infovet
Majalah Peternakan dan Kesehatan Hewan; Ed 67, Pebruari 2000.

5. Joklik WK et al. 1996. Zinsser Microbiology.20th Ed. hal 615-620. 6

. Pohan HT.2005. Patogenesis, Diagnosis dan Penatalaksanaan

Antraks.Majalah Kedokteran Indonesia; vol 55; no 1; hal 23-29.

7. Todar K.2009. Textbook of Bacteriology : Bacillus anthracis & anthrax.

8. Tortora GJ et al.2009.Microbiology.10thEd.Pearson International Edition.

9. Weyant RS et al.2001.Basic Laboratory Protocols for the Presumptive Identification of Bacillus

anthracis.CDC.

10. www.bioterorism.slu.edu. Bioterorism Agent : fact sheet Anthrax /Bacillus anthracis.

11.www.infeksi.com. Pusat Informasi Penyakit Infeksi Rumah Sakit Prof.dr.Sulianti Saroso.

ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL and EPIDEMIOLOGY (APIC). 2005.

Anthrax: Current, Comprehensive Information on Pathogenesis, Microbiology, Epidemiology,
Diagnosis, Treatment, and Prophylaxis, Center for Infectious Disease Research and Policy, University
ofMinnesota,USA.

204

BARNARD, J.P. and A.M. FRIEDLANDER. 1999. Vaccination against anthrax with attenuated
recombinant strains of Bacillus anthracis that produce protective antigen. Infect. hmmunol. --: 562 -
567.

BOYAKA, P.N., A. TAFARO, R. FISCHER, S.H. LEPPLA, K. FUJIHASHI and JR. Mc GEE. 2003. Effective
mucosal immunity to anthrax neutralizing antibodies and the cell response following nasal
immunization with protective antigen. J. Immunol. 176: 5636-5643.

BREY, R.N. 2005. Molecular basic for improved anthrax vaccines. Adv. Drug Deliv. Rev. 57(9): 1266-
1269.

BROSSIER. F., M. LEVY and M. MOCK. 2002. Anthrax spores make an essential contribution to
vaccine efficacy.

KRONMAN, B. VELAN and A. SHAFFERMAN. 2000. Attenuated nontoxigenic and nonencapsulated

recombinantBacillus anthracisspore vaccines protect against anthrax. Infect. Immunol. 68: 4549-
4558.

CONTAGIOUS DISEASE CENTER (CDC). 2002. Comprehensive Procedure for Collecting Environmental
Samples for Culturing Bacillus anthracis, Emergency Preparedness & Response, Atlanta, GA, USA.
COULSON,N.M.,M. FuLOP and R.W. TITBALL. 1994. Bacillus anthracisprotective antigen, expressed in
Salmonella typhimurium SL 3261, affords protections againts anthrax spore challenge. Vaccine 12:
1395 -1401.

DE, B.K., S.L. BRAGG, G.N. SANDEN. K.E. WILSON. L.A. DIEM, C.K. MARSTON, A.R. HOFFMASTER, G.A.
BARNETT, R.S. WEYANT, T.G. ABSHIRE, J.W. EZZELL and T. Popovic. 2002. Two component direct
fluorescent antibody asay for rapid identification of B. anthracis. Emerg. Infect. Dis. 8(10): 1060 -
1065.

DEPARTEMEN KESEHATAN. 2003. Pedoman Tata Laksana Kasus dan Pemeriksaan Laboratorium
Penyakit Antraks di Rumah Sakit. Dirjen Pemberantasan Penyakit Menular dan Penyehatan
Lingkungan. Departemen Kesehatan RI.

FLICK-SMITH, H.C., E.J. EYLES, R. HEBDON, E.L. WATERS, R.J. BEEDHAM, T.J. STAGG, J. MILLER, H.O.
ALPAR, L.W.J. BAILLIE and E.D. WILLIAMSON. 2002. Mucosal or parenteral administration on
microsphere associated Bacillus anthracis protective antigen protects against anthrax infection in
mice. Infect. Immure. 70(4): 2022-2028.

GRINSTEIN,A.R., O. GAT, Z. ALTHOUM, B. VELAN, S. COHEN and A. SHAFFERMAN. 2005. Oral spora
vaccine based on live attenuated nontoxigenic Bacillus anthracis expression recombinant mutant
protective antigen. Infect. Immunol. 73(7): 4043 -4053.

Gu, M.L., S.H. LEPPLA and D.M. KLmivIAN. 2004. Protection against anthrax toxin by vaccination with
a DNA plasmid encoding anthrax protective antigen. Vaccine 17: 340 - 344.

HARDJOUTOMO, S., M.B. POERWADIKARTA, B.E. PATTEN and K. BARKAH. 1993. The application of
ELISA to monitor the vaccinal response of anthrax vaccinated ruminants. Penyakit Hewan Ed. Khusus
46A. 25: 7- 10.

IACONO-CONNORS, L.C., S.L. WELKOS, B.E. IVINS and J.M. DALRYMPLE. 1991. Protection against
anthrax with recombinant virus-expressed protective antigen in experimental animals. Infect.
Immunol. 59: 1961 1965.

IVINS, B.E, S.L. WELKOS, G.B. KNUDSON and S.F. LITTLE. 1990. Immunization againts anthrax with
aromatic compound-dependent (aro) mutants of Bacillus anthracis and with recombinant strains of
Bacillus subtilis that produce anthrax protective antigen. Infect. Immunol. 58: 303 -308.

LEPPLA, S.H.,J.B. ROBBINS, R. SCHNEERSON and J. SHILOACH. 2002. Development of an improved

vaccine for anthrax. J. Clin. Invest. 110(2): 141 - 144.

MULLER, J.D., C.R. WILKS, K.J. O'RILEY , R.J. CONDRON, R. BULL and A. MATECzUN. 2004. Specificty of
an immunochromatographic test for anthrax. Aust. Vet. J. 82(4): 220 -222.

OFFICE INTERNATIONAL DES EPIZOOTIES (OIE). 2000. Anthrax. In: Manual of Standards Diagnostic
and Vaccines, World Health Organization. pp. 235 -239.

PARKINSON, R., A. RAJIC and C. JENSON. 2003. Investigation of a anthrax outbreak in Alberta in 1999
using geographic information system. Can. Vet. J. 44(4): 315-318.

POBOJEWSKI, S. 2004. Anthrax Spore can Germinate, Grow and Reproduce in Soil. University of
Michigan.
SIREGAR, E.A. 2002. Antraks: Sejarah masa lalu, situasi pada saat inn, sejarah diagnosa dan
kecenderungan perkembangan ilmu di masa depan. Simposium Sehari Penyakit Antraks: Antraks di
Indonesia, Masa Lain, Masa Kim dan Masa Depart. Bogor, 17 Juli 2002. Balitvet, Bogor.

SPLINO, M., J. PATOCKA, R. PRYMULA and R. CHLIBEK. 2005. Anthrax vaccine. Ann Saudi Med. 25(2):
143 - 149.

STERNE, M. 1959. Diseases due to bacteria. In: Infectious Diseases of Animals Vol. 1. STABLEFORTH,
A. W. and I.A. GALLOWAY (Eds.). Butterworths, London. UK.

ToDAR, K. 2002. Bacillus anthracis and Anthrax, Departement of Bacteriology, University of

Wisconsin, Madison, USA.

WORLD HEALTH ORGANIZATION (WHO). 1998. Guidelines for the surveillance and control of anthrax
in humans and animals, 3`d Ed. Departement of Communicable Disease Surveillance and Response.
TURNBULL, P.C.B., R. BOHM, O. CosIvi. M. DoGANAY, M.E. HUGH JONES, D.D. Josw, M.K. LALITHA
and V. DE VOS. (Eds.). World Health Organization.

WORLD HEALTH ORGANIZATION (WHO). 1967. Requirements for Anthrax Spore Vaccine (Live - for
Veterinary Use) (Requirements for Biological Substances no. 13). World Health Organization
Technical Report Series 1967 No. 361.